SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-012742
Filing Date
2021-03-02
Accepted
2021-03-02 09:02:49
Documents
3
Period of Report
2021-02-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea136834-8k_inmunebio.htm 8-K 17052
2 PRESS RELEASE DATED FEBRUARY 25, 2021 ea136834ex99-1_inmune.htm EX-99.1 8536
3 GRAPHIC ex99-1_001.jpg GRAPHIC 1869
  Complete submission text file 0001213900-21-012742.txt   29416
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 21701442
SIC: 2836 Biological Products, (No Diagnostic Substances)